cytidine triphosphate has been researched along with Breast Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beijnen, JH; Derissen, EJB; Huitema, ADR; Rosing, H; Schellens, JHM | 1 |
| Huang, M; Lewicki, P; Mitchell, BS; Whang, P | 1 |
1 trial(s) available for cytidine triphosphate and Breast Cancer
| Article | Year |
|---|---|
Intracellular pharmacokinetics of gemcitabine, its deaminated metabolite 2',2'-difluorodeoxyuridine and their nucleotides.
Topics: Activation, Metabolic; Antimetabolites, Antineoplastic; Breast Neoplasms; Cytidine Triphosphate; Deamination; Deoxycytidine; Female; Floxuridine; Gemcitabine; Humans; Leukocytes, Mononuclear; Phosphorylation; Uridine Triphosphate | 2018 |
1 other study(ies) available for cytidine triphosphate and Breast Cancer
| Article | Year |
|---|---|
Cyclopentenyl cytosine induces senescence in breast cancer cells through the nucleolar stress response and activation of p53.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Cell Nucleolus; Cellular Senescence; Cyclin-Dependent Kinase Inhibitor p21; Cytidine; Cytidine Triphosphate; Female; Gene Silencing; Genes, p53; Histones; Humans; Immunohistochemistry; RNA, Small Interfering | 2011 |